Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study.

Leonardi S, Marino M, Crimi G, Maiorana F, Rizzotti D, Lettieri C, Bettari L, Zuccari M, Sganzerla P, Tresoldi S, Adamo M, Ghiringhelli S, Sponzilli C, Pasquetto G, Pavei A, Pedon L, Bassan L, Bollati M, Camisasca P, Trabattoni D, Brancati M, Poli A, Panciroli C, Lettino M, Tarelli G, Tarantini G, De Luca L, Varbella F, Musumeci G, De Servi S.

BMJ Open. 2017 Sep 5;7(9):e016909. doi: 10.1136/bmjopen-2017-016909.

2.
3.

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.

Escaned J, Banning A, Farooq V, Echavarria-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos CM, Stanetic BM, Ishibashi Y, Suwannasom P, Kappetein AP, Taggart D, Morel MA, van Es GA, Serruys PW.

EuroIntervention. 2016 Jun 12;12(2):e224-34. doi: 10.4244/EIJV12I2A36.

4.

A pilot study on the application of the current European guidelines for the management of acute coronary syndrome without elevation of ST segment (NSTEMI) in the Emergency Department setting in the Italian region Lazio.

Valli G, De Marco F, Spina MT, Valeriano V, Rosa A, Minerva V, Mirante E, Ruggieri MP, Pugliese FR; Italian Society of Emergency-Urgency Medicine (SIMEU).

Monaldi Arch Chest Dis. 2014 Dec;82(4):175-82.

5.

[The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].

Silber S, Richartz BM, Brilmayer M; European Society of Cardiology (ESC).

Herz. 2006 Dec;31(9):836-46, 848. German.

PMID:
17180646
6.

Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.

Kocas C, Abaci O, Oktay V, Coskun U, Bostan C, Yildiz A, Arat Ozkan A, Gurmen T, Ersanli M.

J Clin Pharm Ther. 2013 Dec;38(6):476-9. doi: 10.1111/jcpt.12091. Epub 2013 Aug 31.

PMID:
23992279
7.

Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.

Bonzel T, Schächinger V, Dörge H.

Clin Res Cardiol. 2016 May;105(5):388-400. doi: 10.1007/s00392-015-0932-2. Epub 2015 Oct 27.

PMID:
26508415
8.

Measurement of fractional flow reserve in patients with multi-vessel coronary artery disease and borderline lesions prevents unnecessary revascularisation procedures.

Reczuch K, Jankowska E, Telichowski A, Porada A, Banasiak W, Ponikowski P.

Kardiol Pol. 2004 Apr;60(4):311-19; discussion 320-1. English, Polish.

PMID:
15226780
9.

Appropriateness ratings of percutaneous coronary intervention in Japan and its association with the trend of noninvasive testing.

Inohara T, Kohsaka S, Miyata H, Ueda I, Ishikawa S, Ohki T, Nishi Y, Hayashida K, Maekawa Y, Kawamura A, Higashi T, Fukuda K.

JACC Cardiovasc Interv. 2014 Sep;7(9):1000-9. doi: 10.1016/j.jcin.2014.06.006.

10.

Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.

Sukul D, Bhatt DL, Seth M, Zakroysky P, Wojdyla D, Rumsfeld JS, Wang T, Rao SV, Gurm HS.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):342-350. doi: 10.1016/j.jcin.2017.10.042. Epub 2017 Nov 12.

PMID:
29471947
11.

Safety and efficacy of implementing a multidisciplinary heart team approach for revascularization in patients with complex coronary artery disease: an observational cohort pilot study.

Chu D, Anastacio MM, Mulukutla SR, Lee JS, Smith AJ, Marroquin OC, Sanchez CE, Morell VO, Cook CC, Lico SC, Wei LM, Badhwar V.

JAMA Surg. 2014 Nov;149(11):1109-12. doi: 10.1001/jamasurg.2014.2059.

PMID:
25207883
12.

Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.

Desai NR, Bradley SM, Parzynski CS, Nallamothu BK, Chan PS, Spertus JA, Patel MR, Ader J, Soufer A, Krumholz HM, Curtis JP.

JAMA. 2015 Nov 17;314(19):2045-53. doi: 10.1001/jama.2015.13764.

13.

Utility of a real-time appropriate use criteria decision support application for percutaneous coronary interventions in non-acute coronary syndrome.

Chen SH, Ho KK, Gannon SA, Thyagarajan B, Chakrabarti AK, Potter BJ, Singla A, Piccirillo BJ, Meduri CU, Cutlip DE.

Catheter Cardiovasc Interv. 2016 Sep;88(3):E74-9. doi: 10.1002/ccd.26350. Epub 2015 Dec 23.

PMID:
26699241
14.

Appropriateness of percutaneous coronary interventions in Washington State.

Bradley SM, Maynard C, Bryson CL.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):445-53. doi: 10.1161/CIRCOUTCOMES.111.964320. Epub 2012 May 8.

PMID:
22570356
15.

Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).

Lønborg J, Engstrøm T, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L, Høfsten DE; DANAMI 3-PRIMULTI Investigators.

Circ Cardiovasc Interv. 2017 Apr;10(4). pii: e004460. doi: 10.1161/CIRCINTERVENTIONS.116.004460.

PMID:
28404623
16.

Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).

Yang Q, Wang Y, Liu J, Liu J, Hao Y, Smith SC Jr, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Wang W, Zhou Y, Zhao D; CCC-ACS Investigators.

Circ Cardiovasc Interv. 2017 Jun;10(6). pii: e004750. doi: 10.1161/CIRCINTERVENTIONS.116.004750.

PMID:
28606999
17.
18.

Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme - A tertiary centre experience from Western India.

Patil D, Lanjewar C, Vaggar G, Bhargava J, Sabnis G, Pahwa J, Phatarpekar A, Shah H, Kerkar P.

Indian Heart J. 2017 Sep - Oct;69(5):600-606. doi: 10.1016/j.ihj.2016.12.018. Epub 2017 Jan 13.

19.

Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.

Thomas MP, Parzynski CS, Curtis JP, Seth M, Nallamothu BK, Chan PS, Spertus JA, Patel MR, Bradley SM, Gurm HS.

PLoS One. 2015 Sep 17;10(9):e0138251. doi: 10.1371/journal.pone.0138251. eCollection 2015.

20.

Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).

Bradley SM, Chan PS, Hartigan PM, Nallamothu BK, Weintraub WS, Sedlis SP, Dada M, Maron DJ, Kostuk WJ, Berman DS, Teo KK, Mancini GB, Boden WE, Spertus JA.

Am J Cardiol. 2015 Jul 15;116(2):167-73. doi: 10.1016/j.amjcard.2015.03.057. Epub 2015 Apr 17.

PMID:
25960375

Supplemental Content

Support Center